BGNE - BeiGene, Ltd.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue198,220238,3871,0708,816
Cost of Revenue707,710273,99298,03358,250
Gross Profit-509,490-35,605-96,963-49,434
Operating Expenses
Research Development679,005269,018269,018269,018
Selling General and Administrative195,38562,60220,0977,311
Non Recurring----
Others----
Total Operating Expenses903,989336,844118,13065,561
Operating Income or Loss-705,769-98,457-117,060-56,745
Income from Continuing Operations
Total Other Income/Expenses Net15,9407,393-2,103-357
Earnings Before Interest and Taxes-705,769-98,457-117,060-56,745
Interest Expense-9,460-8,295-851-140
Income Before Tax-689,829-91,064-119,163-57,102
Income Tax Expense-15,7962,23554-
Minority Interest14,44514,42214,42214,422
Net Income From Continuing Ops-674,033-93,299-119,217-57,102
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-673,769-93,105-119,217-57,102
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-673,769-93,105-119,217-57,102